Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Timothy Wilkin, MD MPH

Chief, Division of Infectious Diseases and Global Public Health
University of California San Diego
San Diego, CA, United States

Timothy Wilkin, MD MPH is an infectious diseases doctor, Professor of Medicine and Chief of Infectious Diseases and Global Public Health at University of California San Diego. Dr. Wilkin is a clinical trials researcher with a focus on prevention of HPV related cancer in people living with HIV. He receives grant funding from NCI to conduct clinical trials focusing on the use of HPV vaccination in people with HIV, novel HPV immunotherapeutics and prevention of cervical cancer in low- and middle-income countries. He is an active investigator with Advancing Clinical Therapeutics Globally (ACTG) and is the international protocol chair for ACTG A5418/STOMP, a randomized clinical trial of tecovirimat for the treatment of MPox.

Disclosure(s): GSK/ViiV Healthcare: Advisor/Consultant (Terminated); Merck and Company, Inc.: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing)

Presentation(s):